Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q3 2020 Aerpio Pharmaceuticals Inc Earnings Call Transcript

Nov 10, 2020 / 01:30PM GMT
Operator

Greetings. Welcome to the Aerpio Pharmaceuticals Third Quarter 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Gina Marek, Vice President of Finance. You may begin.

Regina Marek
Aerpio Pharmaceuticals, Inc. - Principal Financial Officer, Principal Accounting Officer & VP of Finance

Good morning. Thank you for joining us for Aerpio's Third Quarter 2020 Earnings Call. Joining me on the call today from Aerpio is Joseph Gardner, President and Founder; and Kevin Peters, Chief Science and Medical Officer. This morning, Aerpio released financial results for the third quarter ended September 30, 2020. If you have not received the news release or if you would like to be added to the company's distribution list, you can do so on the Investor Relations page of our website at aerpio.com.

I'd also like to remind you the remarks made on the call today include forward-looking statements about Aerpio. Such statements may include, but are not limited to, those related to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot